Browse > Article

Extended-Spectrum $\beta$-lactamase Genes Acquired Multidrug-Resistant Klebsiella pneumoniae in a Dog and Its Owner  

Han, Jae-Ik (Veterinary Laboratory Medicine, Veterinary Medical Center, Chungbuk National University)
Jang, Hye-Jin (Veterinary Laboratory Medicine, Veterinary Medical Center, Chungbuk National University)
Kim, Gon-Hyung (Veterinary Surgery, Veterinary Medical Center, Chungbuk National University)
Chang, Dong-Woo (Veterinary Radiology, Veterinary Medical Center, Chungbuk National University)
Na, Ki-Jeong (Veterinary Laboratory Medicine, Veterinary Medical Center, Chungbuk National University)
Publication Information
Journal of Veterinary Clinics / v.27, no.2, 2010 , pp. 125-129 More about this Journal
Abstract
A 2-year-old female Pomeranian dog was referred with multiple pelvic fractures. The surgical correction was performed for the fractures. However, after the surgery, purulent exudation was occurred in the surgical site. Antibiotic susceptibility test revealed that the isolated bacteria are resistant to penicillins, cephalosporins, aminoglycosides, quinolones, and trimethoprim/sulfamethoxazole. Bacterial identification and extended-spectrum $\beta$-lactamase (ESBL) confirming test indicated that the isolated bacteriae is ESBL-producing Klebsiella pneumoniae. Minimum inhibitory concentration (MIC) and maximum bactericidal concentration (MBC) tests revealed that meropenem, one of carbapenems, is the only effective antibiotic. The patient was treated with meropenem for 5 days. After 10 days, the exudation was disappeared and the infection was cured. The molecular typing of the ESBL revealed that TEM-1 ESBL is present in the bacteria isolated from the patient. The bacteria isolated from the owner's palm also revealed that TEM-1 and SHV-1 ESBLs are present.
Keywords
Klebsiella pneuminiae; extended-spectrum $\beta$-lactamase; TEM; SHV; meropenem;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y, Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN, Kohno S, SENTRY Asia-Pacific Participants. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005; 52: 323-329.   DOI   ScienceOn
2 Mouton JW, Touzw DJ, Horrevorts AM, Vinks AA. Comparative pharmacokinet-ics of the carbapenems: clinical implications. Clin Pharmacokinet 2000; 39: 185-201.   DOI   ScienceOn
3 Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extendedspectrum betalactamases. Clin Infect Dis 2004; 39: 31-37.   DOI   ScienceOn
4 Pitout JDD, Laupland KB. Extended-spectrum $\beta-lactamaseproducing$ Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166.   DOI   ScienceOn
5 Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBLs). Clin Microbiol Infect 2000; 6: 460-463.   DOI   ScienceOn
6 Yu WL, Chuang YC, Jones RN. A pragmatic approach to identify extended-spctrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan: in vitro activity of newer and established antimicrobial agents. Diagn Microbiol Infect Dis 2004; 48: 277-282.   DOI   ScienceOn
7 Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. Effects of phenotype and genotype on methods for detection of extended-spectrum-$\beta$-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007; 45: 199-205.   DOI   ScienceOn
8 Yu WL, Chuang YC, Rasmussen JW. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006; 39: 264-277.
9 Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spctrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001; 39: 2206-2212.   DOI   ScienceOn
10 Paterson DL. Extended-spectrum beta-lactamases: the European experience. Curr Opin Infect Dis 2001; 14: 697-701.   DOI   ScienceOn
11 Rupp ME, Fey PD. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003; 63: 353-365.   DOI   ScienceOn
12 Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-686.   DOI   ScienceOn
13 Martinez-Freijo P, Fluit AC, Schmitz FJ, Grek VS, Verhoef J, Jones ME. Class I integrons in gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 1998; 42: 689-696.   DOI
14 National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Disk diffusion. 15th Informational supplement. NCCLS document M100-S15. Wayen, Pa: National Committee for Clinical Laboratory Standards; 2005.
15 Norby SR. Neurotoxicity of carbapenems antibacterials. Drug Saf 1996; 15: 87-90.   DOI   ScienceOn
16 Levesque C, Piche L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-191.   DOI   ScienceOn
17 Lamotte-Brasseur J, Knox J, Kelly JA, Charlier P, Fonze E, Dideberg O, Frere JM. The structures and catalytic mechanisms of active-site serine beta-lactamases. Biotechnol Genet Eng Rev 1994; 12: 189-230.   DOI   ScienceOn
18 Lee SH, Kim MN, Choi SJ, Chung WS. Characteristics of extended-spectrum $\beta-lactamase$ of Escherichia coli strains isolated from clinical specimens. Korean J Clin Pathol 2000; 20: 400-409.
19 Leverstein-van Hall MA, Box ATA, Blok HEM, Paauw A, Fluit AC, Verhoef J. Evidence of extensive interspecies transfer of integron-mediatd antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J Infect Dis 2002; 186: 49-56.   DOI   ScienceOn
20 Liao CH, Sheng WH, Wang JT, Sun HY, Wang HK, Hsueh PR, Chen YC, Chang SC. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan. J Microbiol Immunol Infect 2006; 39: 59-66.
21 Jones LA, Mciver CJ, Kim MJ, Rawlinson WD, White PA. The aadB gene cassette is associated with $bla_{SHV}$ genes in Klebsiella species producing extended-spctrum $\beta-lactamases$. Antimicrob Agents Chemother 2005; 49: 794-797.   DOI   ScienceOn
22 Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 5: 375-382.
23 Holten KB, Onusko EM. Appropriate prescribing of oral betalactam antibiotics. Am Fam Physician 2000; 62: 611-620.
24 Jacoby GA. Genetics of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13: 2-11.   DOI
25 Kim BN, Woo JH, Kim MN, Ryu J, Kim YS. Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002; 52: 99-106.   DOI   ScienceOn
26 Haeggman S, Lofdahl S, Paauw A, Verhoef J, Brisse S. Diversity and evolution of the class A chromosomal betalactamase gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 2400-2408.   DOI   ScienceOn
27 Alvan G, Nord CE. Adverse effects of monobactams and carbapenems. Drug Saf 1995; 12: 305-313.   DOI   ScienceOn
28 Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.   DOI   ScienceOn
29 Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-1233.   DOI   ScienceOn
30 Dzidic S, Bedekovic V. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin 2003; 24: 519-526.